No Data
Hong Kong stocks movement | CRO Concept stocks rose broadly in the morning as Innovative Drugs continue to expand overseas. The Global interest rate cuts help improve CXO overseas Business.
CRO Concept stocks experienced a general rise in the morning session. As of the time of writing, FRONTAGE (01521) rose by 5.88%, trading at 1.8 HKD; WUXI APPTEC (02359) rose by 4.97%, trading at 57 HKD; WUXI BIO (02269) rose by 3.64%, trading at 18.2 HKD; PHARMARON (03759) rose by 3.21%, trading at 14.14 HKD.
Frontage Holdings Corporation's (HKG:1521) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Is the rebound trend of Hong Kong stocks established? The Hang Seng Index temporarily returned to 20,000 points, and the performance of Cryptos stocks is eye-catching.
① How do Institutions view the phenomenon of the Hong Kong stock market warming up? ② What news primarily drives the rising trend of pharmaceutical stocks?
China Securities Co.,Ltd.: An outlook on the pharmaceutical Industry 2024 annual report.
In 2025, the Industry is expected to achieve moderate growth and overall move towards high-quality development.
Frontage Holdings Appoints Co-CEOs
FRONTAGE (01521.HK): Wentao Zhang and Zhongping Lin have been promoted to co-CEOs.
Gelonghui, January 6th | FRONTAGE (01521.HK) announced that Dr. Abdul Mutlib has decided to step down from his current position as the company's CEO effective January 6, 2025, to facilitate the company's leadership succession plan. As of January 6, 2025, Dr. Wentao Zhang, the Chief Strategy Officer of the company's wholly-owned subsidiary Frontage Laboratories, Inc. ('Frontage Labs'), and
Despite Hitting HK$1.67, Frontage Holdings Insiders Still Sold Too Soon
